Skip to content

US · ZJYL · MEDICAL - INSTRUMENTS & SUPPLIES

Jin Medical International Ltd. (ZJYL) intrinsic value and stock valuation

$3.38as of 2026-11-21 · Mkt cap 17.3M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Jin Medical International Ltd. DCF and intrinsic value

InvestorsCraft values ZJYL with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from ZJYL’s statements →

Jin Medical International Ltd. Graham Number

Graham Number: $3.59d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Instruments & Supplies Changzhou, JS zhjmedical.com

How the business is doing

Fiscal 2018–2025, USD

Revenue
$20.7M+5% 5y CAGRd
20182025
Net income
$1.19M-11.6% 5y CAGRd
20182025
Free cash flow
-$-3.73M
20182025
Total equity
$29.6M+22.3% 5y CAGRd
20182025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2025, USD
20252024202320222021
Revenue$20.7M$23.5M$19.8M$19.2M$20.8M
Operating income$610K$3.64M$2.87M$2.13M$2.63M
Net income$1.19M$3.68M$2.88M$2.71M$2.63M
EPSd$152K$470.6K$396.7K$401.5K$196.6K
Operating cash flow$2.9M-$-1.21M$3.11M$1.58M$5.84M
Capital expenditure-$-6.63M-$-1.12M-$-110K-$-40K-$-40K
Free cash flow-$-3.73M-$-2.33M$2.99M$1.54M$5.8M
Total assets$53.4M$45.8M$32.9M$20.9M$21.9M
Total debt$18.9M$11.6M$4.11M$0.00$0.00
Net debt$11.5M$3.47M-$-2.82M-$-4.79M-$-3.67M
Total equity$29.6M$28.6M$24M$15.2M$14M
Cash and short-term investments$29.6M$26.8M$16.7M$7.07M$5.73M
Income statement
20252024202320222021
Revenue$20.7M$23.5M$19.8M$19.2M$20.8M
Cost of revenue$14.6M$14M$13M$13M$14.4M
Gross profit$6.04M$9.5M$6.78M$6.2M$6.36M
Research and development expenses$1.56M$1.5M$1.54M$1.89M$1.57M
Selling, general and administrative expenses$3.88M$4.37M$2.37M$2.18M$2.16M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$5.44M$5.86M$3.92M$4.07M$3.73M
Cost and expenses$20.1M$19.9M$17M$17.1M$18.1M
Interest income$790K$470K$180K$180K$0.00
Interest expense$0.00$0.00$0.00$0.00$10K
Depreciation and amortization$320K$350K$230K$360K$340K
Ebitda$930K$3.98M$3.09M$3.1M$3.23M
Operating income$610K$3.64M$2.87M$2.13M$2.63M
Total other income/expenses, net$990K$540K$350K$610K$250K
Income before tax$1.6M$4.18M$3.22M$2.74M$2.88M
Income tax expense$210K$760K$340K$40K$250K
Net income$1.19M$3.68M$2.88M$2.71M$2.63M
Weighted average shares outstanding$7.83M$7.82M$7.26M$6.75M$13.4M
Weighted average diluted shares outstanding$7.83M$7.82M$7.26M$6.75M$13.4M
Balance sheet
20252024202320222021
Cash and short-term investments$29.6M$26.8M$16.7M$7.07M$5.73M
Net receivables$6.8M$8.78M$8.5M$4.25M$5.98M
Inventory$4.92M$7.12M$5.86M$6.88M$7.04M
Total current assets$44.1M$42.8M$31.1M$18.9M$19.4M
Property, plant and equipment, net$7.98M$1.72M$1.48M$1.63M$2.11M
Goodwill and intangible assets$1.1M$1.15M$150K$160K$190K
Long-term investments$0.00$0.00-$-150K-$0.00$0.00
Total non-current assets$9.23M$2.98M$1.79M$2.04M$2.48M
Total assets$53.4M$45.8M$32.9M$20.9M$21.9M
Accounts payable$3.26M$3.01M$3.39M$4.11M$5.35M
Short-term debt$18.9M$11.5M$4.11M$0.00$0.00
Deferred revenue$610K$800K$830K$830K$1.68M
Total current liabilities$23.8M$17.2M$8.92M$5.7M$7.87M
Long-term debt$0.00$100K$0.00$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$0.00$100K$0.00$0.00$0.00
Capital lease obligations$70K$280K$0.00$0.00$0.00
Total liabilities$23.8M$17.3M$8.92M$5.7M$7.87M
Common stock$10K$10K$10K$10K$10K
Retained earnings$20.9M$20M$16.9M$14.4M$11.9M
Accumulated other comprehensive income (loss)$1.94M$2.04M$610K$740K$2.06M
Total equity$29.6M$28.6M$24M$15.2M$14M
Total investments$22.2M$18.6M$9.62M$2.28M$2.05M
Total debt$18.9M$11.6M$4.11M$0.00$0.00
Net debt$11.5M$3.47M-$-2.82M-$-4.79M-$-3.67M
Cash flow statement
20252024202320222021
Net income$1.38M$3.42M$2.88M$2.71M$2.63M
Depreciation and amortization$350K$350K$230K$360K$350K
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital$1.1M-$-4.92M-$-200K-$-1.43M$2.96M
Accounts receivable$2.27M-$-3.91M-$-380K$330K$3.08M
Inventory$170K$80K$1.56M-$-500K$460K
Accounts payable$290K-$-500K-$-650K-$-810K-$-370K
Net cash provided by operating activities$2.9M-$-1.21M$3.11M$1.58M$5.84M
Investments in property, plant and equipment-$-6.63M-$-140K-$-110K-$-40K-$-40K
Acquisitions, net-$-500K$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-10.79M-$-9.51M-$-7.73M-$-120K-$-1.07M
Common stock issued$0.00$310K$8M$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$7.35M$11.7M$6.91M$120K-$-2.87M
Net change in cash-$-670K$1.21M$2.14M$1.12M$2.01M
Cash at end of period$7.46M$8.14M$6.93M$4.79M$3.67M
Operating cash flow$2.9M-$-1.21M$3.11M$1.58M$5.84M
Capital expenditure-$-6.63M-$-1.12M-$-110K-$-40K-$-40K
Free cash flow-$-3.73M-$-2.33M$2.99M$1.54M$5.8M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Jin Medical International Ltd.

        Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.

        CEO
        Erqi Wang
        Employees
        273
        Beta
        7.34

        Explore

        Frequently asked questions

        What is the intrinsic value of Jin Medical International Ltd. (ZJYL)?

        InvestorsCraft does not currently publish an intrinsic value for ZJYL. How the IC value is calculated.

        Is ZJYL undervalued?

        InvestorsCraft does not publish an undervaluation signal for ZJYL at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.